Increasing Age Affected Polymorphonuclear Neutrophils in Prognosis of Mycoplasma pneumoniae Pneumonia

Qianye Zhao1,2, Teng Zhang2, Beibei Zhu1

  • 1Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.

Abstract

Insights

Age significantly impacts Mycoplasma pneumoniae pneumonia (MPP) outcomes. Older children with refractory MPP exhibit increased polymorphonuclear neutrophils (PMNs), suggesting age is a key factor in disease severity and development.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae pneumonia (MPP) is a common childhood infection.
  • The influence of patient age on MPP prognosis and severity is not fully understood.
  • Refractory MPP (RMPP) represents a severe form of the disease with unclear contributing factors.

Purpose of the Study:

  • To investigate the role of age in the prognosis and development of Mycoplasma pneumoniae pneumonia (MPP).
  • To identify risk factors associated with refractory MPP (RMPP).
  • To explore age-related differences in immune cell function and lung injury in MPP.

Main Methods:

  • Retrospective analysis of 1875 hospitalized children with pneumonia, identifying RMPP and non-RMPP cases.
  • Logistic regression analysis to determine risk factors for RMPP, with age and polymorphonuclear neutrophils (PMNs) identified as key.
  • Cellular and molecular analysis of PMNs from children with MPP, stratified by an age cut-off of 4.5 years, and a murine model of MPP.

Main Results:

  • Higher age and PMNs count were significantly associated with RMPP compared to non-RMPP.
  • A linear correlation was observed between patient age and PMNs percentage in RMPP cases.
  • Age-related differences in PMNs function, apoptosis, mitochondrial activity, and oxidative stress were noted in children with MPP; age also influenced MPP pathogenesis in a mouse model.

Conclusions:

  • Age is a significant factor influencing the development and severity of refractory Mycoplasma pneumoniae pneumonia (RMPP).
  • Increased PMNs activity and altered immune responses in older children may contribute to RMPP.
  • Age-related mechanisms are implicated in MPP pathogenesis, warranting further investigation.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
95
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
34
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
51
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
30
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
33
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
41